Tucatinib is a kinase inhibitor indicated in combination with trastuzumab and capecitabine for the treatment of adults with advanced unresectable or metastatic HER2-positive breast cancer, including those with brain metastases, who have received one or more prior anti-HER2-based regimens in the metastatic setting.<\/p>\n
TUKYSA\u00ae (tucatinib) tablets, for oral use Initial U.S. Approval: 2020 <\/strong><\/p>\n TUKYSA (tucatinib) may be accessed in India through a named-patient import process<\/strong>\u00a0with a valid doctor\u2019s prescription, and\u00a0Indian Pharma Network (IPN), New Delhi, assists with compliant sourcing<\/strong>\u00a0and delivery of specialty medicines subject to regulatory approvals.<\/p>\n Indian Pharma Network (IPN), based in New Delhi, helps patients and healthcare providers with the sourcing and import coordination of specialty medicines in compliance with applicable Indian regulations.<\/strong>\u00a0Availability, import eligibility, pricing, and delivery timelines may vary and are subject to regulatory approvals and documentation requirements.<\/p>\n IPN having representation in<\/strong>\u00a0Delhi, Gurugram, Mumbai, Bengaluru, Kolkata, Chennai, Pune, Ahmedabad, Hyderabad, Chandigarh, Jaipur, and Lucknow.<\/p>\n Named-patient import facilitator contact details<\/strong> Patients are advised to independently verify the credentials, licensing, and regulatory compliance of any facilitator before proceeding.<\/em><\/p>\n Note:<\/strong><\/em> Tukysa is a cancer medicine that is used\u00a0to treat breast cancer that is locally advanced or metastatic (has spread to other parts of the body) and when it is HER2-positive<\/b>. This means the cancer cells produce a protein on their surface, HER2, which stimulates the growth of the cancer.<\/p>\nIs TUKYSA (tucatinib) available in India?<\/h4>\n
How to get TUKYSA Tablets delivered in India?<\/h4>\n
Who can help source TUKYSA Tablets in India legally?<\/h4>\n
\nCompany Name:<\/strong>\u00a0Indian Pharma Network (IPN)
\nAddress:<\/strong>\u00a060\/4 1st Floor, T&T Building, Indian Oil Complex, Yusuf Sarai, Delhi 110016
\nFor sourcing and import coordination of specialty medicines, contact:<\/strong>
\nMr. Tarun:<\/strong>\u00a0+91 9891 296 838
\nMr. Neeraj:<\/strong>\u00a0+91 9811 747 774
\nEmail:\u00a0info@indianpharmanetwork.co.in<\/a><\/strong><\/p>\nNEWS \/ UPDATES<\/h4>\n
\n
\nWe are the facilitator, group of highly qualified healthcare professionals, provide solutions on how to get access of anti cancer medicines not available in India. On the basis of permission in Form 12B (Import permit) from From Ministry of Health, Government of India, IPN, New Delhi procure drugs on behalf of patient.\u00a0Indian Pharma Network (IPN) serves as a legitimate consultant and facilitator situated in New Delhi, India<\/a>. With over two decades of industry experience, IPN offers extensive coverage across India.<\/em><\/p>\n","protected":false},"excerpt":{"rendered":"TUKYSA (tucatinib) is used to treat breast cancer.<\/h2>\n
\n\n
\n Brand Name:<\/strong><\/td>\n TUKYSA<\/td>\n<\/tr>\n \n Generic Name:<\/strong><\/td>\n tucatinib<\/td>\n<\/tr>\n \n Strength:<\/strong><\/td>\n \u2022 Tablets: 50 mg and 150 mg.<\/td>\n<\/tr>\n \n Manufacturer:<\/strong><\/td>\n Seagen<\/td>\n<\/tr>\n \n Approved By:<\/strong><\/td>\n EMA, USFDA<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n